• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用行政索赔数据研究脑转移瘤:一项验证性研究。

Utility of administrative claims data for the study of brain metastases: a validation study.

机构信息

Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, 55 Fruit Street, Yawkey 9E, Boston, MA, 02114, USA.

Department of Neurology, Harvard Medical School, Boston, MA, USA.

出版信息

J Neurooncol. 2009 Dec;95(3):427-431. doi: 10.1007/s11060-009-9943-z. Epub 2009 Jun 27.

DOI:10.1007/s11060-009-9943-z
PMID:19562256
Abstract

In this study, we sought to determine the accuracy with which the International Classification of Diseases, 9th Edition, Clinical Modification (ICD-9-CM) diagnosis code for "secondary neoplasm of brain and spinal cord" in health insurance claims measures clinically evident central nervous system (CNS) metastases in patients with non-small cell lung cancer (NSCLC). For 241 consecutive patients with newly diagnosed NSCLC, we compared ICD-9-CM "secondary neoplasm" codes indicating tumor spread to the CNS from institutional billing records to gold-standard chart review to determine: (1) sensitivity, specificity and positive predictive value (PPV) of the site-specific secondary neoplasm code and (2) the accuracy in time of its appearance within billing records compared with the gold standard date of CNS relapse. The occurrence of at least one ICD-9-CM code for brain metastasis (Algorithm 1) had a sensitivity of 100% (95% CI: 100-100%) and PPV of 91% (95% CI: 87-94%). By requiring >or= 2 codes (Algorithm 2) or >or= 3 codes (Algorithm 3) for the diagnosis of brain metastasis in claims, specificity and PPV improved, while sensitivity did not drop substantially. The claims-based date of diagnosis was also accurate, with 92% of dates falling within 30 days of the gold standard. ICD-9-CM codes in institutional billing claims reliably documented NSCLC metastases to the CNS. These results suggest that Medicare claims data may be used to evaluate clinical and epidemiological issues related to brain metastases in elderly cancer patients.

摘要

在这项研究中,我们旨在确定医疗保险索赔中使用的国际疾病分类第 9 版临床修订版(ICD-9-CM)诊断代码“脑和脊髓继发肿瘤”用于测量非小细胞肺癌(NSCLC)患者临床明显的中枢神经系统(CNS)转移的准确性。我们对 241 例连续确诊的 NSCLC 患者进行了研究,将 ICD-9-CM“继发肿瘤”代码指示肿瘤向 CNS 扩散的情况与机构计费记录的金标准图表审查进行了比较,以确定:(1)特定部位继发肿瘤代码的敏感性、特异性和阳性预测值(PPV);(2)与 CNS 复发的金标准日期相比,计费记录中该代码出现的时间准确性。至少有一个脑转移 ICD-9-CM 代码(算法 1)的出现具有 100%的敏感性(95%CI:100-100%)和 91%的 PPV(95%CI:87-94%)。通过在索赔中要求>或=2 个代码(算法 2)或>或=3 个代码(算法 3)来诊断脑转移,特异性和 PPV 提高,而敏感性没有大幅下降。基于索赔的诊断日期也很准确,92%的日期与金标准相差 30 天以内。机构计费索赔中的 ICD-9-CM 代码可靠地记录了 NSCLC 向 CNS 的转移。这些结果表明,医疗保险索赔数据可用于评估与老年癌症患者脑转移相关的临床和流行病学问题。

相似文献

1
Utility of administrative claims data for the study of brain metastases: a validation study.利用行政索赔数据研究脑转移瘤:一项验证性研究。
J Neurooncol. 2009 Dec;95(3):427-431. doi: 10.1007/s11060-009-9943-z. Epub 2009 Jun 27.
2
Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans.行政索赔识别肺癌新发病例的敏感性:3个健康计划的比较
J Manag Care Pharm. 2009 Oct;15(8):659-68. doi: 10.18553/jmcp.2009.15.8.659.
3
Hospital-activity data inaccurate for determining spread-of-disease at diagnosis for non-small cell lung cancer.医院活动数据在确定非小细胞肺癌诊断时的疾病传播方面并不准确。
Aust N Z J Public Health. 2012 Jun;36(3):212-7. doi: 10.1111/j.1753-6405.2012.00850.x. Epub 2012 Feb 23.
4
Validation of body mass index (BMI)-related ICD-9-CM and ICD-10-CM administrative diagnosis codes recorded in US claims data.验证美国索赔数据中与体重指数(BMI)相关的 ICD-9-CM 和 ICD-10-CM 行政诊断代码。
Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1092-1100. doi: 10.1002/pds.4617. Epub 2018 Jul 12.
5
Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.医疗保险索赔中诊断代码对识别癌症转移和推断分期的有效性有限。
Ann Epidemiol. 2014 Sep;24(9):666-72, 672.e1-2. doi: 10.1016/j.annepidem.2014.06.099. Epub 2014 Jul 3.
6
Bayesian estimation of the accuracy of ICD-9-CM- and CPT-4-based algorithms to identify cholecystectomy procedures in administrative data without a reference standard.在无参考标准的情况下,基于ICD - 9 - CM和CPT - 4算法从管理数据中识别胆囊切除术的贝叶斯准确性估计。
Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):263-8. doi: 10.1002/pds.3870. Epub 2015 Sep 9.
7
Validation of ICD-9-CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients.验证 ICD-9-CM 代码在住院类风湿关节炎患者的行政索赔数据中识别胃肠道穿孔事件的有效性。
Pharmacoepidemiol Drug Saf. 2011 Nov;20(11):1150-8. doi: 10.1002/pds.2215. Epub 2011 Aug 27.
8
Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis.淋巴结大小可预测非小细胞肺癌患者在诊断时的无症状脑转移。
Clin Lung Cancer. 2019 Jan;20(1):e107-e114. doi: 10.1016/j.cllc.2018.09.014. Epub 2018 Sep 24.
9
Derivation and Validation of ICD-10 Codes for Identifying Incident Stroke.ICD-10 编码用于识别中风事件的推导和验证。
JAMA Neurol. 2024 Aug 1;81(8):875-881. doi: 10.1001/jamaneurol.2024.2044.
10
Chiari malformation Type I surgery in pediatric patients. Part 1: validation of an ICD-9-CM code search algorithm.小儿患者的Ⅰ型Chiari畸形手术。第1部分:ICD-9-CM编码搜索算法的验证。
J Neurosurg Pediatr. 2016 May;17(5):519-24. doi: 10.3171/2015.10.PEDS15370. Epub 2016 Jan 22.

引用本文的文献

1
The association between toxicity and efficacy of immune checkpoint inhibitors in older adults with NSCLC.免疫检查点抑制剂在老年非小细胞肺癌患者中的毒性与疗效的相关性。
Immunotherapy. 2024;16(16-17):1057-1068. doi: 10.1080/1750743X.2024.2394382. Epub 2024 Sep 13.
2
Hospital variation of outcomes in status epilepticus.癫痫持续状态的医院结局差异。
Epilepsia. 2024 May;65(5):1415-1427. doi: 10.1111/epi.17927. Epub 2024 Feb 26.
3
Comparable safety profile between neuro-oncology procedures involving stereotactic needle biopsy (SNB) followed by laser interstitial thermal therapy (LITT) and LITT alone procedures.

本文引用的文献

1
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344).利用美国国立综合癌症网络乳腺癌试验参与者的医疗保险理赔数据来测量无病生存期和癌症复发情况(9344的配套研究)
J Natl Cancer Inst. 2006 Sep 20;98(18):1335-8. doi: 10.1093/jnci/djj363.
2
Brain metastases: epidemiology and pathophysiology.脑转移瘤:流行病学与病理生理学
J Neurooncol. 2005 Oct;75(1):5-14. doi: 10.1007/s11060-004-8093-6.
3
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
涉及立体定向针吸活检(SNB)后进行激光间质热疗(LITT)的神经肿瘤学手术与单纯LITT手术之间具有可比的安全性。
J Neurooncol. 2023 Mar;162(1):147-156. doi: 10.1007/s11060-023-04275-w. Epub 2023 Mar 15.
4
COVID-19 Diagnosis and Risk of Death Among Adults With Cancer in Indiana: Retrospective Cohort Study.印第安纳州成年癌症患者的COVID-19诊断与死亡风险:回顾性队列研究
JMIR Cancer. 2022 Oct 6;8(4):e35310. doi: 10.2196/35310.
5
Readmission risk of malignant brain tumor patients undergoing laser interstitial thermal therapy (LITT) and stereotactic needle biopsy (SNB): a covariate balancing weights analysis of the National Readmissions Database (NRD).行激光间质热疗(LITT)和立体定向针活检(SNB)的恶性脑肿瘤患者再入院风险:国家再入院数据库(NRD)的协变量平衡权重分析。
J Neurooncol. 2022 Sep;159(3):553-561. doi: 10.1007/s11060-022-04093-6. Epub 2022 Jul 23.
6
Frequency, etiologies, risk factors, and sequelae of falls among patients with brain metastases: A population- and institutional-level analysis.脑转移患者跌倒的频率、病因、危险因素及后遗症:一项基于人群和机构层面的分析。
Neurooncol Pract. 2021 Nov 1;9(2):114-122. doi: 10.1093/nop/npab061. eCollection 2022 Apr.
7
Emergency department visits and inpatient hospitalizations among older patients with brain metastases: a dual population- and institution-level analysis.老年脑转移瘤患者的急诊科就诊和住院情况:基于人群和机构层面的双重分析
Neurooncol Pract. 2021 May 21;8(5):569-580. doi: 10.1093/nop/npab029. eCollection 2021 Oct.
8
Epidemiology of brain metastases and leptomeningeal disease.脑转移瘤和软脑膜疾病的流行病学。
Neuro Oncol. 2021 Sep 1;23(9):1447-1456. doi: 10.1093/neuonc/noab101.
9
Clinical Data Prediction Model to Identify Patients With Early-Stage Pancreatic Cancer.临床数据预测模型,用于识别早期胰腺癌患者。
JCO Clin Cancer Inform. 2021 Mar;5:279-287. doi: 10.1200/CCI.20.00137.
10
Population-based estimates of survival among elderly patients with brain metastases.基于人群的脑转移老年患者生存率估计。
Neuro Oncol. 2021 Apr 12;23(4):661-676. doi: 10.1093/neuonc/noaa233.
医疗保险化疗理赔在癌症与白血病B组乳腺癌和肺癌试验参与者中的标准效度。
J Natl Cancer Inst. 2005 Jul 20;97(14):1080-3. doi: 10.1093/jnci/dji189.
4
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.在底特律大都市癌症监测系统中确诊(1973年至2001年)的患者中脑转移瘤的发病比例。
J Clin Oncol. 2004 Jul 15;22(14):2865-72. doi: 10.1200/JCO.2004.12.149.
5
Participation in cancer clinical trials: race-, sex-, and age-based disparities.参与癌症临床试验:基于种族、性别和年龄的差异。
JAMA. 2004 Jun 9;291(22):2720-6. doi: 10.1001/jama.291.22.2720.
6
Identifying cancer relapse using SEER-Medicare data.利用监测、流行病学和最终结果(SEER)-医疗保险数据识别癌症复发。
Med Care. 2002 Aug;40(8 Suppl):IV-75-81. doi: 10.1097/00005650-200208001-00011.
7
Studying radiation therapy using SEER-Medicare-linked data.利用与监测、流行病学和最终结果(SEER)计划及医疗保险相关联的数据研究放射治疗。
Med Care. 2002 Aug;40(8 Suppl):IV-49-54. doi: 10.1097/00005650-200208001-00007.
8
Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.一组乳腺癌、结肠癌、肾癌、肺癌患者及黑色素瘤患者中脑转移瘤的发病率。
Cancer. 2002 May 15;94(10):2698-705. doi: 10.1002/cncr.10541.
9
Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.医疗保险乳腺癌手术治疗理赔数据的准确性和完整性。
Med Care. 2000 Jul;38(7):719-27. doi: 10.1097/00005650-200007000-00004.
10
Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.医疗保险理赔与肿瘤登记数据在癌症相关治疗评估方面的一致性。
Med Care. 2000 Apr;38(4):411-21. doi: 10.1097/00005650-200004000-00008.